Rosuvastatin Clinical Trials

4 actively recruiting trials across 3 locations

▲ +1 trial since May 2026

Also known as: Rosuvastatin 10 mg, Rosuvastatin 20 mg

Pipeline

Phase 1: 1Phase 2: 1Phase 4: 2

Top Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
Nanjing First Hospital, Nanjing Medical University1
Massachusetts General Hospital1
AstraZeneca1

Indications

Heart Disease2
Coronary Artery Disease2
Cirrhosis Alcoholic1
Cirrhosis Infectious1
Cirrhosis Advanced1

Other1 trial

Effects of Inclisiran Combined With Statins on the Morphology of Coronary Vulnerable Plaques

Phase 4

Glendale, California1 trial

A Study to Investigate the Effect of Elecoglipron on Rosuvastatin and Atorvastatin in Healthy Participants

Research Site

Phase 1

La Jolla, California1 trial

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

University of California San Diego NAFLD Research Center

Phase 2

Boston, Massachusetts1 trial

Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine

Massachusetts General Hospital

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.